Changes in body weight and serum liver tests associated with parenteral nutrition compared with no parenteral nutrition in patients with acute myeloid leukemia during remission induction treatment

Rianne van Lieshout*, Lidwine W. Tick, Jeanne P. Dieleman, Stephanie Custers, Marieke S. van Dongen, Debbie van der Lee, Anne R. Schaaphok, Merel Snellen, Harry C. Schouten, Sandra Beijer

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Web of Science)

Abstract

Purpose Differences in body weight changes and serum liver tests (LTs) in acute myeloid leukemia (AML) patients receiving parenteral nutrition (PN) versus no PN during remission induction (RI) treatment were assessed. Methods Retrospectively, differences in body weight changes and serum LTs in AML patients (n = 213) who received PN versus no PN during RI treatment in one of three Dutch hospitals between 2004 and 2015 were assessed. Weekly body weight and serum LT registrations were collected from medical records. Patients' body weight changes were compared between the hospitals where PN is applied upon first indication of inadequate oral intake (PN hospitals) and the hospital where use of PN is limited to severe cases only (no-PN hospital) using repeated measures mixed model analysis. Differences in severity of serum LT elevations, according to the Common Terminology Criteria for Adverse Events (CTCAE) version 4.0, were assessed between patients who did and did not receive PN using chi-square or Fisher's exact tests, and multiple logistic regression analysis. Results Compared with patients of the PN hospitals, patients of the no-PN hospital experienced significantly more body weight loss during RI treatment (between-group difference 7.2%, 95% CI 4.0-10.3%). Furthermore, PN was associated with transient mild to moderate elevations of liver enzymes, but not with raised median total bilirubin levels nor with occurrence of CTCAE grade 3-4 LT elevations. Conclusion Frequent compared with exceptional use of PN in AML patients during RI treatment better preserved body weight, without clinically relevant (CTCAE grade 3-4) elevations in serum LTs.

Original languageEnglish
Pages (from-to)4381-4393
Number of pages13
JournalSupportive Care in Cancer
Volume28
Issue number9
DOIs
Publication statusPublished - Sep 2020

Keywords

  • Acute myeloid leukemia
  • Remission induction treatment
  • Parenteral nutrition
  • Body weight loss
  • Serum liver tests
  • STEM-CELL TRANSPLANTATION
  • MASS INDEX
  • SUPPORT
  • ADULTS
  • COMPLICATIONS
  • IMPACT
  • RECOMMENDATIONS
  • GUIDELINES
  • PARAMETERS
  • DIAGNOSIS

Cite this